MIAMI BEACH, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced the opening of its newest center in Raleigh, NC. The Raleigh location increases the company’s center count to 27 locations throughout the United States, Canada and the UK.
AirSculpt® is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt locations. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
“We are thrilled to bring AirSculpt to Raleigh,” said Todd Magazine, Chief Executive Officer at AirSculpt® Technologies. “Our Charlotte location has delivered great results for North Carolinians so we are pleased to be able to deliver more location choices for potential patients.”
The Raleigh location is conveniently located in a prime spot between downtown Raleigh and Durham. The new office is located at 8510 Colonnade Center Drive, Suite 100, Raleigh, NC and can be reached at (919) 391-3750.
More than 40,000 AirSculpt cases have been performed in AirSculpt’s premium locations throughout the U.S, Canada and the United Kingdom. For additional information about scheduling a virtual or in-person consultation at any of the 27 centers, visit airsculpt.com.
About AirSculpt®
AirSculpt® is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.
Investor Contact:
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Contact:
Stephanie Evans Greene
Chief Marketing Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$5.61 |
| Daily Change: | 0.09 1.63 |
| Daily Volume: | 9,319 |
| Market Cap: | US$322.800M |
February 27, 2024 November 09, 2023 October 05, 2023 September 07, 2023 August 11, 2023 | |
Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
